Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis

BACKGROUND AND AIM: Immune checkpoint inhibitors (ICIs) have been widely used in hepatocellular carcinoma (HCC), while only a subset of patients experience clinical benefit. We aimed to investigate the effects of viral etiology on response to ICIs in HCC and depict the tumor immune microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ziniu, Dong, Zhaoru, Chen, Zhiqiang, Hong, Jianguo, Yan, Lunjie, Li, Haichao, Yao, Shengyu, Yan, Yuchuan, Yang, Yafei, Yang, Chuncheng, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511422/
https://www.ncbi.nlm.nih.gov/pubmed/34659220
http://dx.doi.org/10.3389/fimmu.2021.733530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511422/
https://www.ncbi.nlm.nih.gov/pubmed/34659220
http://dx.doi.org/10.3389/fimmu.2021.733530

Ejemplares similares